BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  AgeX Therapeutics CEO Michael D. West to Participate in Roundtable Panel on the Path Forward for Stem Cell Therapy at Termis Americas’ Annual Conference

  This year’s conference will focus on the theme, “The Path Forward for Regenerative Medicine: Traversing the Lab to the Patient.”

  December 4, 2017

   · 

  3 min read
• 

  Business

  Biogen Continues Bulking Up Its C-Suite With Appointment of Ex-Takeda Exec as CIO

  Mr. Hernon joins Biogen with more than 30 years of experience in IT and strategic leadership.

  December 4, 2017

   · 

  4 min read
• Business

  Ncardia and Evotec Entered a Licencing Agreement for Disease Modelling Using iPS Cells

  Under the terms of the agreement, Evotec has broad access to Ncardia’s stem cell derived cellular disease modelling IP.

  December 4, 2017

   · 

  3 min read
• BioForest

  Seattle Genetics to Webcast Investor and Analyst Event at American Society of Hematology Annual Meeting on December 11.

  Industry experts will discuss the ADCETRIS (brentuximab vedotin) phase 3 ECHELON-1 data, and members of the Seattle Genetics management team will discuss other program highlights.

  December 4, 2017

   · 

  1 min read
• Drug Development

  Ironwood Reports Top-line Phase IIa Data for IW-1973 Demonstrating Positive Cardiovascular, Metabolic and Endothelial Effects

  These studies confirm a pharmacokinetic profile of IW-1973 supporting once-daily dosing and suggest broad distribution to tissues, offering the potential for extra-vascular pharmacology.

  December 4, 2017

   · 

  10 min read
• Deals

  Exactech and TPG Capital Announce Amended Merger Agreement Providing for Increase in Merger Consideration to $49.25 Per Share

  Exactech announced today that it has entered into an amendment to its merger agreement with TPG Capital and certain of its affiliates which was previously announced on October 23, 2017.

  December 4, 2017

   · 

  9 min read
• Biotech Bay

  Biotime’s Additional Renevia Data From the Successful Pivotal Trial Was Presented at the IFATS Conference

  The Renevia data was presented by primary investigator Ramon Llull, MD, PhD, Director of Stem Europe Mallorca Center, Mallorca, Spain at the “Plenary Session 2 - Clinical Studies with SVF.”

  December 4, 2017

   · 

  4 min read
• Biotech Beach

  NantKwest to Present Data at the 59th Annual Meeting of the American Society of Hematology

  This oral presentation will present preclinical data on the company’s CD19.taNK program.

  December 4, 2017

   · 

  4 min read
• Business

  Bioasis Implements Transition Plan for Its Board of Directors

  Bioasis announced that Rob Hutchison and Michael Hutchison have submitted their planned resignations from the board.

  December 4, 2017

   · 

  5 min read
• 

  Drug Development

  AstraZeneca Investors Rejoice After COPD Drug Performs in Phase IV Study

  Tudorza, also marketed as Eklira and Bretaris, is available in more than 50 countries.

  December 4, 2017

   · 

  6 min read